Brief: Castle Biosciences 2025 Total Revenue Expected To Exceed $340 Million
11/01/2026 21:02
Jan 11 (Reuters) - Castle Biosciences Inc CSTL.O: CASTLE BIOSCIENCES ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL–YEAR 2025 RESULTS CASTLE BIOSCIENCES INC - 2025 TOTAL REVENUE EXPECTED TO EXCEED $340 MILLION, ABOVE PREVIOUSLY GUIDED RANGE OF $327-335 MILLION Source text: ID:nGNX5L2Z7C Further company coverage: CSTL.O ((Reuters.briefs@thomsonreuters.com;))
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million